HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

International Cooperation on Alternative Test Methods

This article was originally published in The Rose Sheet

Executive Summary

Alternative method validation organizations from U.S., EU and Japan, together with Health Canada, adopt framework for International Cooperation on Alternative Test Methods, announces European Center for the Validation of Alternative Methods (ECVAM). Initiative is product of September 2007 meeting of the International Cooperation on Cosmetics Regulation, which covered a range of issues including nanotechnology and good manufacturing practices (1"The Rose Sheet" Oct. 15, 2007, p. 4). ICCR also "recognized the importance of replacing, reducing and refining (less pain and distress) animal testing." Framework allows participating organizations to coordinate in designing validation studies, conducting scientific peer reviews and finally developing harmonized recommendations, according to ECVAM, which is joined by U.S. counterpart - the Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) - as well as the Japanese Center for the Validation of Alternative Methods and a Canadian government rep. Under adopted schema, one validation organization will act as lead, drafting recommendations based on liaisons with others; if all parties are in agreement, they will finalize and forward recommendation to their respective regulatory authorities

You may also be interested in...



FDA to hold ICCR prep meeting

FDA will hold a public meeting July 7 in Rockville, Md., to prepare for International Cooperation of Cosmetic Regulations meetings being held week of July 12 in Toronto, Canada, according to June 9 Federal Register notice. The Rockville forum will allow agency to furnish information and solicit comment in advance of the ICCR steering committee and expert working group meetings. A coalition formed by regulatory authorities from the U.S., Canada, EU and Japan, ICCR aims to harmonize cosmetics regulations on a global scale and lower barriers to trade while maintaining consumer protections (1"The Rose Sheet" Nov. 3, 2008, In Brief)

ICCR in Tokyo

FDA will hold a public meeting Sept. 2 in College Park, Md. to prepare for International Cooperation on Cosmetics Regulations meeting being held Sept. 7 in Tokyo, Japan, according to pre-publication notice for the Federal Register. Meeting will be held to provide information and solicit comment in advance of ICCR steering committee and expert working group meetings. Those interested in participating must register with the FDA Office of the Commissioner. A coalition formed by regulatory authorities from the U.S., Canada, EU and Japan, ICCR aims to harmonize cosmetics regulations on global scale and lower barriers to trade while maintaining consumer protections (1"The Rose Sheet," Nov. 3, 2008, In Brief)

ICCR Addresses Cosmetic Labeling, Nanotechnology At First Meeting

The International Cooperation on Cosmetics Regulation invites the cosmetics industry to generate and submit data showing that U.S. consumers understand the meaning of "trivial names" on product labeling

Related Content

UsernamePublicRestriction

Register

RS015763

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel